INHIBITORS OF TESTOSTERONE 5α-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TESTOSTERONE 5α-REDUCTASE ACTIVITY Russian patent published in 1999 - IPC

Abstract RU 2141967 C1

FIELD: organic chemistry, biochemistry. SUBSTANCE: invention describes an inhibitor of testosterone 5α-reductase of the molecular formula (I) 5α where dotted line means optional pi-bond; 5α means hydrogen atom or methyl-group but if the indicated optional bond is absent then it does not mean hydrogen atom; means hydrogen atom; R4 means hydrogen atom; R6 means hydrogen atom or lower alkyl and R7 means R17α-alkyl or aryl tertiary amino-group or R17β-alkyl or aryl amido-group. New compounds can be used for treatment of patients with androgen-sensitive diseases course of that can be delayed by inhibition of androgenic receptors activation. Invention describes also a composition based on compounds of the formula (I) and a method of inhibition of activity of testosterone C1-C7-reductase. EFFECT: valuable curative properties of compounds. 8 cl, 8 dwg, 8 tbl, 19 ex

Similar patents RU2141967C1

Title Year Author Number
ANTIANDROGENIC COMPOUNDS, PRECURSOR OF ANTIANDROGENIC COMPOUND, PHARMACEUTICAL COMPOSITIONS 1993
  • Fernand Labri
  • Iv Merand
  • Shankar M.Singkh
RU2141966C1
BENZOPIPERIDINE DERIVATIVES, BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON SAID 1992
  • Fernand Labri
  • Iv Merand
RU2142945C1
FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION 1993
  • Akille Pantseri
  • Marchella Nesi
  • Ehnriko Di Salle
RU2125061C1
INDOLIZINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF ACTIVITY OF TESTOSTERONE-5α-REDUCTASE 1992
  • Satosi Okada
  • Kozo Savada
  • Akio Kuroda
  • Sinija Vatanabe
  • Khirokazu Tanaka
RU2120942C1
16-SUBSTITUTED 4-AZAANDROSTANES, COMPOUNDS, METHODS OF INHIBITION, PHARMACEUTICAL COMPOSITION 1994
  • Filippe L.D'Jurette
  • Uil'Jam K.Khagmann
  • Tomas Dzh.Lantsa
  • Soumia P.Sakhoo
  • Gari Kh.Rasmusson
  • Richard L.Tolman
  • Derek Von Langen
RU2142956C1
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE 1992
  • Glenn Dzh.Gomlej
  • Ehlizabet Stoner
RU2125879C1
17$$$-SUBSTITUTED 3-CARBOXYSTEROIDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION 1992
  • Akille Pantseri[It]
  • Marchella Nesi[It]
  • Ehnriko Di Salle[It]
RU2104283C1
17-HALOGEN-4-AZAANDROSTENE DERIVATIVES AND METHOD OF PREPARATION THEREOF 1993
  • Tuba Zoltan[Hu]
  • Selesh Janosh[Hu]
  • Balog Gabor[Hu]
  • Khorvat Judit[Hu]
  • Lovashne Marshai Marija[Hu]
RU2103275C1
METHOD OF PREPARING 7β--SUBSTITUTED 4-AZA -5α- ANDROSTAN- 3-ONES AND METHOD OF PREPARING SUBSTITUTED 7β- ALKYL ANDROST-5-EN-3-ONES 1993
  • Raman K.Bakshi
  • Gari Kh.Rasmusson
RU2114117C1
ANDROSTEN(ANE) (ONE) DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF, METHODS OF PREPARATION THEREOF, AND METHOD OF MEDICAL TREATMENT 1994
  • Behchelor Kennet Uil'Jam
  • Fraj Stiven Vernon
RU2144037C1

RU 2 141 967 C1

Authors

Fernand Labri

Iv Meran

Shankar M.Singkh

Dates

1999-11-27Published

1993-05-06Filed